BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28130989)

  • 1. Comparison of the discriminative stimulus and response rate effects of
    Wiley JL; Lefever TW; Marusich JA; Craft RM
    Drug Alcohol Depend; 2017 Mar; 172():51-59. PubMed ID: 28130989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JWH-018 in rhesus monkeys: differential antagonism of discriminative stimulus, rate-decreasing, and hypothermic effects.
    Rodriguez JS; McMahon LR
    Eur J Pharmacol; 2014 Oct; 740():151-9. PubMed ID: 24972243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice.
    McMahon LR; Ginsburg BC; Lamb RJ
    Psychopharmacology (Berl); 2008 Jul; 198(4):487-95. PubMed ID: 17673980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus effects of the cannabinoid CB1 antagonist SR 141716A in rhesus monkeys pretreated with Delta9-tetrahydrocannabinol.
    McMahon LR
    Psychopharmacology (Berl); 2006 Oct; 188(3):306-14. PubMed ID: 16953389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.
    Wiley JL; Lefever TW; Cortes RA; Marusich JA
    Pharmacol Biochem Behav; 2014 Sep; 124():123-8. PubMed ID: 24887450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Δ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice.
    Gatch MB; Forster MJ
    Behav Pharmacol; 2014 Dec; 25(8):750-7. PubMed ID: 25325289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug discrimination properties and cytotoxicity of the cannabinoid receptor ligands].
    Tomiyama K; Funada M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Jun; 47(3):135-43. PubMed ID: 22894054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent Affinity Estimates and Reversal of the Effects of Synthetic Cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by Rimonabant in Rhesus Monkeys.
    Hruba L; McMahon LR
    J Pharmacol Exp Ther; 2017 Aug; 362(2):278-286. PubMed ID: 28533288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats.
    Järbe TU; LeMay BJ; Halikhedkar A; Wood J; Vadivel SK; Zvonok A; Makriyannis A
    Psychopharmacology (Berl); 2014 Feb; 231(3):489-500. PubMed ID: 24005529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys.
    Ginsburg BC; Schulze DR; Hruba L; McMahon LR
    J Pharmacol Exp Ther; 2012 Jan; 340(1):37-45. PubMed ID: 21965552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cannabinoid agonist HU-210: pseudo-irreversible discriminative stimulus effects in rhesus monkeys.
    Hruba L; McMahon LR
    Eur J Pharmacol; 2014 Mar; 727():35-42. PubMed ID: 24486701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rimonabant-induced Delta9-tetrahydrocannabinol withdrawal in rhesus monkeys: discriminative stimulus effects and other withdrawal signs.
    Stewart JL; McMahon LR
    J Pharmacol Exp Ther; 2010 Jul; 334(1):347-56. PubMed ID: 20375197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Δ
    Rowton SS; Rocha BA; Porter IE
    J Pharmacol Toxicol Methods; 2020; 106():106937. PubMed ID: 33096236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids.
    McMahon LR
    Br J Pharmacol; 2011 Mar; 162(5):1060-73. PubMed ID: 21091643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
    Wiley JL; Marusich JA; Lefever TW; Grabenauer M; Moore KN; Thomas BF
    Neuropharmacology; 2013 Dec; 75():145-54. PubMed ID: 23916483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Δ
    Gatch MB; Forster MJ
    Psychopharmacology (Berl); 2018 Mar; 235(3):673-680. PubMed ID: 29138877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminative stimulus functions of methanandamide and delta(9)-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol.
    Järbe TU; Li C; Vadivel SK; Makriyannis A
    Psychopharmacology (Berl); 2010 Jan; 208(1):87-98. PubMed ID: 19902182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
    Darmani NA; Janoyan JJ; Crim J; Ramirez J
    Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminative stimulus properties of Cannabis sativa terpenes in rats.
    Carey LM; Ghodrati S; France CP
    Behav Pharmacol; 2024 Jun; 35(4):161-171. PubMed ID: 38660819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.